+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07459049

Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non-Surgical Periodontal Therapy A Randomized Clinical Trial

Led by University of Baghdad · Updated on 2026-03-09

30

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effect of Ibuprofen on reducing the acute inflammatory response after one-stage non-surgical periodontal therapy in adults with periodontitis. The study aims to answer whether Ibuprofen effectively lowers markers of inflammation such as hs-CRP, Procalcitonin, and IL-6 following this dental treatment. This is a randomized clinical trial focused on patients with generalized unstable periodontitis and a pocket depth of 4 mm or more. Participants will first attend a baseline visit where demographic information, clinical examination, and baseline blood samples will be collected. All will receive scaling and oral hygiene instructions, and one week later, clinical parameters will be recorded again. The test group will receive Ibuprofen doses starting one hour before root surface debridement and continuing three times daily for three days, while the control group will undergo the same dental procedure without Ibuprofen. Root surface debridement will be performed by a single periodontist, and treatment duration will be recorded. Participants will attend a follow-up visit one week after root surface debridement to collect blood samples, complete a pain questionnaire, and record plaque index to assess oral hygiene compliance. The main outcomes measured are changes in systemic inflammatory markers after seven days and postoperative pain using a visual analog scale. The study involves active monitoring of clinical parameters and patient-reported pain over the course of one week following treatment.

CONDITIONS

Brief Title

"Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy"

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Systemically healthy patients
  • Have at least 20 teeth
  • Diagnosed with generalized unstable periodontitis
  • Pocket depth of 4 mm or more
  • Adults aged 18 years or older
  • Both smokers and non-smokers are eligible
Not Eligible

You will not qualify if you...

  • Allergy or hypersensitivity to Ibuprofen or other NSAIDs
  • Current systemic anti-inflammatory or antibiotic therapy within the past 3 months
  • History of peptic ulcer disease
  • Received periodontal therapy within the past 3 months
  • Asthma
  • Renal impairment
  • Hepatic impairment
  • Severe cardiac disease including heart failure or hypertension
  • Bleeding disorders or use of anticoagulants
  • Known or suspected high risk for tuberculosis, hepatitis B, or HIV infections
  • Pregnant or lactating females
  • Unable to provide written informed consent

Research Team

N

Nabaa Ismail Ibrahim, B.D.S

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here